|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B显示文摘 | Jens M. Kittner Martin F. Sprinzl Annette Grambihler Arndt Weinmann J?rn M. Schattenberg Peter R. Galle Marcus Schuchmann | 2012 | Journal of Clinical Virology2012，，1： | 2 |
| 2 | Extracorporeal membrane oxygenation for acute respiratory distress syndrome in burn patients:a case series and literature update显示文摘Background:Acute respiratory distress syndrome(ARDS)has a reported incidence of 34–43%in ventilated burn patients and is associated with a mortality of 59%in the severe form.The use and experience with extracorporeal membrane oxygenation(ECMO)in burn patients developing ARDS are still limited.We present our results and discuss the significance of ECMO in treating burn patients.Methods:A retrospective analysis of burn patients treated with ECMO for ARDS between January 2017 and January 2019 was performed.Demographic,clinical,and outcome data were collected and analyzed.Results:Eight burn patients were treated at our institution with ECMO in the designated time period.Of these,all but one patient had inhalation injury,burn percentage of TBSA was 37±23%,ABSI score was 8.4±2,and R-Bauxscore was 98±21.Seven patients developed severe ARDS and one patient moderate ARDS according to the Berlin classification with a PaO_(2)/FiO_(2) ratio upon initiation of ECMO therapy of 62±22 mmHg.ECMO duration was 388±283 h.Three patients died from severe sepsis while five patients survived to hospital discharge.Conclusions:ECMO is a viable therapy option in burn patients developing severe ARDS and can contribute to survival rates similar to ECMO therapy in non-burn-associated severe ARDS.Consequently,patients with severe respiratory insufficiency with unsuccessful conventional treatment and suspected worsening should be transferred to burn units with the possibility of ECMO treatment to improve outcome. | Mehran Dadras Johannes M.Wagner Christoph Wallner Julika Huber Dirk Buchwald Justus Strauch Kamran Harati Nicolai Kapalschinski Björn Behr Marcus Lehnhardt | 2019 | Burns & Trauma2019，7，1： | 2 |
| 3 | Lack of Association Between the MEF2A Gene and Myocardial Infarction显示文摘 | Wolfgang Lieb Bj?rn Mayer Inke R. K?nig Iris Borwitzky Anika G?tz Silke Kain Christian Hengstenberg Patrick Linsel-Nitschke Marcus Fischer Angela D?ring H -Erich Wichmann Thomas Meitinger Reinhold Kreutz Andreas Ziegler Heribert Schunkert Jeanette Erdmann | 2008 | Circulation2008，，2： | 1 |
| 4 | A prospective, muhicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: broad effectiveness trial with aripiprazole ( BETA ) 显示文摘 | Tandon R Marcus RN Stock EG | 2006 | Schizophr Res2006，84，： | 1 |
| 5 | Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study显示文摘 | Byerly M J Marcus RN Tran QV | 2009 | Schizophr Res2009，107，23： | 1 |
| 6 | Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double- blind, placebo- controlled comparison with intramuscular haloperidol显示文摘 | ANDREZINA R JOSIASSEN RC MARCUS RN et ol | 2006 | Psychopharmacology(Berl)2006，188，3： | 1 |
| 7 | Efficacy and safety of intramuscular aripiprazole in patients with acute agitation : a randomized, double - blind, placebo- controlled trial 显示文摘 | TRAN-JOHNSON TK SACK DA MARCUS RN | 2007 | J Clin Psychiatry2007，68，1： | 1 |
| 8 | Aripiprazole in the treatmentof irritability in children and adolescents with autistic disorder显示文摘 | Owen R Sikich L Marcus RN | 2009 | Pediatrics2009，124，： | 1 |
| 9 | A placebo - controlled,fixed - dose study of aripiprazole in children and adolescents with ir-ritability associated with autistic disorder显示文摘 | Marcus RN Owen R Kamen L | 2009 | J Am Acad Child Ad-olesc Psychiatry2009，48，： | 1 |
| 10 | Prospective, multicenter, randomized, parallel - group, open - label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: broad effectiveness trial with aripiprazole ( BETA ) 显示文摘 | Tandon R Marcus RN Stock EG | 2006 | Schizophr Res2006，84，： | 1 |
| 11 | Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic,stable schizophrenia:a 52-week,open-label comparison with olanzapine显示文摘 | ChrzanowsKi WK Marcus RN Torbeyns A | | 0，，： | 1 |
| 12 | A prospective,multicenter,randomized,parallel-group,open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice:Broad Effectiveness Trial With Aripiprazole (BETA)显示文摘 | Tandon R Marcus RN Stock EG | 2006 | Schizophr Res2006，84，1： | 1 |
| 13 | Efficacy and safety of aripipazo|e as adjunctive therapy in major de pressive disorder显示文摘 | Marcus RN McQuade RD Carson WH | 2008 | J Clin Psychopharmacol2008，28，2： | 1 |
| 14 | Effectiveness oflong - term aripiprazole therapy in patients with acutely relapsingor chronic, stable schizophrenia : a 52 - week,open - label compar-ison with olanzapine显示文摘 | Chrzanowski WK Marcus RN Torbeyns A | 2006 | Psychopharmacololgy ( Berl)2006，189，： | 1 |
| 15 | Downregulation of organic cation transporter 1 (SLC22A1) is associatedwith tumor progression and reduced patient survival in human cholangiocellularcarcinoma显示文摘 | Anja Lautem Michael Heise Andreas Gr?sel Maria Hoppe?Lotichius Nina Weiler Daniel Foltys Johanna Knapstein J?rn Schattenberg Arno Schad Anca Zimmermann Gerd Otto Hauke Lang Peter Galle Marcus Schuchmann Tim Zimmermann | 2013 | International Journal of Oncology2013，，4： | 1 |
| 16 | A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder显示文摘 | Marcus RN Owen R Kamen L Manos G McQuade RD Carson WH | 2009 | J Am Acad Child Adolesc Psychiatry2009，48，11： | 1 |
| 17 | Effica cy and safety of aripipazole as adjunctive therapy in major de pressive disorder显示文摘 | Marcus RN McQuade RD Carson WH | 2008 | J Clin Psychopharmacology2008，28，2： | 1 |
| 18 | Efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder显示文摘 | Marcus RN McQuade RD Carson WH | 2008 | Schizophr Res2008，98，1： | 1 |
| 19 | The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder : a multicenter, randomized, double- blind, placebo- controlled study显示文摘 | Berman RM Marcus RN Swanink R | 2007 | J Clin Psychiatry2007，68，6： | 1 |
| 20 | Aripiprazole in the treatment of irirritability in children and adolescents with autistic disorder 显示文摘 | Owen R Sikich L Marcus RN Corey-Lisle P Manos G Mc- Quade RD | 2009 | Pediatrics2009，124，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员